Prosthetic Heart Valve Market - Forecasts from 2018 to 2023

March 2018 | 94 pages | ID: PE2DB9B334BEN
Knowledge Sourcing Intelligence LLP

Abstracts

The global prosthetic heart valve market was valued at US$5.131 billion in 2017 and is projected to expand at a CAGR of 10.98% over the forecast period to reach US$9.589 billion by 2023. Prosthetic heart valves are used in cardiac surgical procedures where a diseased or an abnormal valve is replaced by an artificial heart. Factors driving growth in the market are, increasing cases of valvular heart disease (VHD), favorable government regulations, technological advancements in treatment procedures, rising health awareness and reimbursements. Geographically, North America is expected to hold the largest market share for the global prosthetic heart valve market while Asia Pacific is highly emerging mainly due to the improving healthcare infrastructure in this region.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Prosthetic Heart Valve value chain. Last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global Prosthetic Heart Valve market.

Major industry players profiled as part of the report are Medtronic, Boston Scientific Corporation, Terumo Europe N.V., Abbott and Edwards Lifesciences Corporation among others.

SEGMENTATION

The global Prosthetic Heart Valve market has been analyzed through following segments:

• By Type
• Mechanical Heart Valve
• Tissue Heart Valve
• By End Users
• Hospitals and Clinics
• Research Laboratories
• Others
• By Geography
• Americas
• United States
• Canada
• Brazil
• Others
• Europe Middle East and Africa
• United Kingdom
• Germany
• France
• Netherlands
• Others
• Asia Pacific
• China
• Japan
• India
• Australia
• Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. GLOBAL PROSTHETIC HEART VALVE MARKET BY TYPE

5.1. Mechanical Heart Valve
5.2. Tissue Heart Valve

6. GLOBAL PROSTHETIC HEART VALVE MARKET BY END USERS

6.1. Hospitals and Clinics
6.2. Research Laboratories
6.3. Others

7. GLOBAL PROSTHETIC HEART VALVE MARKET BY GEOGRAPHY

7.1. Americas
  7.1.1. United States
  7.1.2. Canada
  7.1.3. Brazil
  7.1.4. Others
7.2. Europe Middle East and Africa
  7.2.1. United Kingdom
  7.2.2. Germany
  7.2.3. France
  7.2.4. Netherlands
  7.2.5. Others
7.3. Asia Pacific
  7.3.1. China
  7.3.2. Japan
  7.3.3. India
  7.3.4. Australia
  7.3.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Market Share Analysis
8.2. Recent Deals and Investment
8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. Boston Scientific Corporation
  9.1.1. Company Overview
  9.1.2. Financials
  9.1.3. Products and Services
  9.1.4. Recent Developments
9.2. Edwards Lifesciences Corporation
  9.2.1. Company Overview
  9.2.2. Financials
  9.2.3. Products and Services
  9.2.4. Recent Developments
9.3. Abbott
  9.3.1. Company Overview
  9.3.2. Financials
  9.3.3. Products and Services
  9.3.4. Recent Developments
9.4. Medtronic
  9.4.1. Company Overview
  9.4.2. Financials
  9.4.3. Products and Services
  9.4.4. Recent Developments
9.5. JenaValve Technology, Inc.
  9.5.1. Company Overview
  9.5.2. Financials
  9.5.3. Products and Services
  9.5.4. Recent Developments
9.6. CryoLife, Inc.
  9.6.1. Company Overview
  9.6.2. Financials
  9.6.3. Products and Services
  9.6.4. Recent Developments
9.7. LivaNova PLC
  9.7.1. Company Overview
  9.7.2. Financials
  9.7.3. Products and Services
  9.7.4. Recent Developments
9.8. Terumo Europe N.V.
  9.8.1. Company Overview
  9.8.2. Financials
  9.8.3. Products and Services
  9.8.4. Recent Developments
9.9. Cook Biotech, Inc.
  9.9.1. Company Overview
  9.9.2. Financials
  9.9.3. Products and Services
  9.9.4. Recent Developments
9.10. Lepu Medical Technology Co., Ltd.
  9.10.1. Company Overview
  9.10.2. Financials
  9.10.3. Products and Services
  9.10.4. Recent Developments